tiprankstipranks
Trending News
More News >

BONESUPPORT Announces CEO Transition to Drive Future Growth

Story Highlights
  • BONESUPPORT specializes in innovative injectable bio-ceramic bone graft substitutes.
  • Emil Billbäck steps down as CEO, with Torbjörn Sköld taking over on September 1, 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

BONESUPPORT HOLDING AB ( (SE:BONEX) ) has issued an announcement.

BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, while Torbjörn Sköld will assume the CEO role starting September 1, 2025. This change is expected to leverage Sköld’s extensive experience in MedTech and leadership to further advance the company’s mission of transforming bone injury care. The transition is seen as a strategic move to continue the company’s growth trajectory and strengthen its market position.

More about BONESUPPORT HOLDING AB

BONESUPPORT is a leading company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel to the patient’s own bone and have the capability of eluting drugs. The company is based in Lund, Sweden, and reported net sales of SEK 899 million in 2024.

YTD Price Performance: -20.24%

Average Trading Volume: 361

Technical Sentiment Signal: Sell

Current Market Cap: $2.16B

See more insights into BONEX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App